Cellmyx is committed to advancing the art of aesthetic and regenerative injectables. We design, patent, and manufacture proprietary medical products for the harvesting, processing, and deployment of FDA 361 compliant autologous soft tissue. We continue to explore novel concepts to enhance the development of our proprietary product portfolio.
Cellmyx has spent the last two decades delving into the literature on autologous fat grafting to ensure that the products we create are backed by science. From fat transfer for breast augmentation or Brazilian butt-lifts, to microfat and regenerative stem cells for orthopedic applications, we’ve developed a suite of medical products to allow doctors to perform every procedure under the sun relating to liposuction and fat transfer.
Read more about the advances in fat grafting and the science behind our adipose tissue products.